Inorganic arsenite-induced malignant transformation of human prostate epithelial cells

Journal of the National Cancer Institute

Volumn 94, Issue 24, 2002, Pages 1888-1891

  Achanzar, William E ^a   Brambila, Eduardo M ^a   Diwan, Bhalchandra A ^b   Webber, Mukta M ^c   Waalkes, Michael P ^a  

^a National Cancer Institute   (United States)

^b SAIC FREDERICK INC   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; GELATINASE B;

ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; ENZYME RELEASE; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; TUMOR DIFFERENTIATION;

EID: 0037132695     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/94.24.1888     Document Type: Article

References (24)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47.
2. Key TJ. Hormones and cancer in humans. Mutat Res 1995;333:59-67.
3. Wu MM, Kuo TL, Hwang YH, Chen CJ. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 1989;130:1123-32.
4. Chen CJ, Wang CJ. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res 1990;50:5470-4.
5. Lewis DR, Southwick JW, Ouellet-Hellstrom R, Rench J, Calderon RL. Drinking water arsenic in Utah: a cohort mortality study. Environ Health Perspect 1999; 107: 359-65.
6. IARC. Some Metals and Metallic Compounds. In: IARC Monograph on the evaluation of the carcinogenic risk of chemicals to humans. Vol. 23. Lyon (France): IARC; 1980. p. 39-142.
7. IARC. Some metals and metallic compounds. In: IARC monograph on the evaluation of the carcinogenic risk to humans-overall evaluations of carcinogenicity: an update of IARC Monographs 1 to 42. Suppl. 7. Lyon (France): IARC; 1987. p. 100-3.
8. Zhao CQ, Young MR, Diwan BA, Coogan TP, Waalkes MP. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci U S A 1997;94:10907-12.
9. Chen H, Liu J, Merrick BA, Waalkes MP. Genetic events associated with arsenic-induced malignant transformation: applications of cDNA microarray technology. Mol Carcinog 2001;30:79-87.
10. Chen H, Liu J, Zhao, CQ, Diwan BA, Merrick BA, Waalkes MP. Association of c-myc overexpression and hyperproliferation with arsenite-induced malignant transformation. Toxicol Appl Pharmacol 2001;175:260-8.
11. Liu J, Chen H, Miller DS, Saavedra JE, Keefer LK, Johnson DR, et al. Overexpression of glutathione S-transferase π and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic. Mol Pharmacol 2001;60:302-9.
12. Bello D, Webber MM, Kleinman HK, Wartinger DD, Rhim JS. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis 1997;18:1215-23.
13. Webber MM, Bello D, Kleinman HK, Hoffman MP. Acinar differentiation by nonmalignant immortalized human prostate epithelial cells and its loss by malignant cells. Carcinogenesis 1997;18:1225-31.
14. Webber MM, Waghray A, Bello D, Rhim JS. Proteases and invasion in human prostate epithelial cell lines: implications in prostate cancer prevention and intervention. Radiat Oncol Invest 1996:3:358-62.
15. Achanzar WE, Diwan BA, Liu J, Quader S, Webber MM, Waalkes MP. Cadmium-induced malignant transformation of human prostate epithelial cells. Cancer Res 2001;61: 455-8.
16. Hamdy FC, Fadlon EJ, Cottam D, Lawry J, Thurrell W, Silcocks PB, et al. Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia. Br J Cancer 1994;69: 177-82.
17. Festuccia C, Bologna M, Vicentini C, Tacconelli A, Miano R, Violini S, et al. Increased matrix metalloproteinase-9 secretion in short-term tissue cultures of prostatic tumor cells. Int J Cancer 1996;69:386-93.
18. Prasad SC, Thraves PJ, Dritschilo A, Rhim JS, Kuettel MR. Cytoskeletal changes during radiation-induced neoplastic transformation of human prostate epithelial cells. Scanning Microsc 1996;10:1093-102.
19. Rossman TG, Visalli MA, Uddin AN, Hu Y. Human cell models of arsenic carcinogenicity and toxicity: transformation and genetic susceptibility. In: Chappell WR, Abernathy CO, Calderon RL, editors. Arsenic exposure and health effects IV. Amsterdam (The Netherlands): Elsevier; 2001. p. 285-95.
20. National Research Council. Arsenic in the drinking water. Washington (DQ: National Academy Press; 1999.
21. Kitchin KT. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol Appl Pharmacol 2001;172:249-61.
22. Basu A, Mahata J, Gupta S, Giri AK. Genetic toxicology of a paradoxical human carcinogen, arsenic: a review. Mutat Res 2001;488: 171-94.
23. Rossman TG, Uddin AN, Burns FJ, Bosland MC. Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin: an animal model for arsenic carcinogenesis. Toxicol Appl Pharmacol 2001;176:64-71
24. Lu T, Liu J, LeCluyse EL, Zhou YS, Cheng ML, Waalkes MP. Application of cDNA microarray to the study of arsenic-induced liver diseases in the population of Guizhou, China. Toxicol Sci 2001;59:185-92.